FDA Warning Letter — Boehringer Ingelheim Pharma GmbH & Co. KG
The FDA took a Warning Letter action against Boehringer Ingelheim Pharma GmbH & Co. KG on May 6, 2013 (Ingelheim am Rhein, Germany). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Date
- May 6, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Center
- CDER
- Location
- Ingelheim am Rhein (Germany)